{"nct_id":"NCT03136653","title":"A Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma","status":"COMPLETED","status_verified_date":"2021-08","start_date":"2017-05-23","start_date_type":"ACTUAL","primary_completion_date":"2020-10-12","primary_completion_date_type":"ACTUAL","completion_date":"2021-01-13","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["MOLN"]}